Cholic Acid 相關新聞
Cholic Acid 目前有 0 則相關新聞報導,預測適應症 20 個。
本頁整合 Cholic Acid 的 AI 預測適應症與最新健康新聞,橘色標示的適應症表示近期有相關新聞報導。
藥物資訊
- 原適應症:Orphacol is indicated for the treatment of inborn errors in primary bile acid synthesis due to3β-Hydroxy-Δ5-C27-steroid oxidoreductase deficiency or Δ4-3-Oxosteroid-5β-reductase deficiency ininfants,...
- 證據等級:L5
- 預測適應症(20 個):
- cholelithiasis(99.9%)
- HIV infectious disease(99.8%)
- obsolete familial combined hyperlipidemia(99.8%)
- homozygous familial hypercholesterolemia(99.8%)
- biotin metabolic disease(99.7%)
- vitamin deficiency disorder(99.7%)
- hereditary hemochromatosis(99.7%)
- neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter(99.7%)
- hemosiderosis(99.7%)
- disorder of phenylalanine metabolism(99.6%)
- bone Paget disease(99.6%)
- inborn error of biotin metabolism(99.6%)
- feline acquired immunodeficiency syndrome(99.6%)
- simian immunodeficiency virus infection(99.6%)
- obsolete rare hereditary hemochromatosis(99.5%)
- hyperphenylalaninemia due to tetrahydrobiopterin deficiency(99.5%)
- inborn disorder of pyridoxine metabolism(99.5%)
- Wilson disease(99.4%)
- constitutional megaloblastic anemia due to folate metabolism disorder(99.4%)
- cerebral folate deficiency(99.4%)
相關新聞(0 則)
目前沒有相關新聞報導。當有新聞提到此藥物時,系統會自動收集並顯示在這裡。
免責聲明:本頁新聞由系統自動收集,僅供研究參考,不構成醫療建議。